South Dakota Investment Council Lowers Holdings in Humana Inc. (HUM)

South Dakota Investment Council reduced its stake in shares of Humana Inc. (NYSE:HUM) by 21.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,548 shares of the insurance provider’s stock after selling 13,630 shares during the quarter. South Dakota Investment Council’s holdings in Humana were worth $11,682,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of HUM. Glen Harbor Capital Management LLC bought a new stake in shares of Humana during the first quarter valued at about $525,000. First Trust Advisors LP raised its stake in shares of Humana by 306.2% during the first quarter. First Trust Advisors LP now owns 94,588 shares of the insurance provider’s stock valued at $19,498,000 after purchasing an additional 71,301 shares in the last quarter. Advisors Asset Management Inc. raised its stake in shares of Humana by 195.9% during the first quarter. Advisors Asset Management Inc. now owns 2,681 shares of the insurance provider’s stock valued at $553,000 after purchasing an additional 1,775 shares in the last quarter. Flinton Capital Management LLC bought a new stake in shares of Humana during the first quarter valued at about $300,000. Finally, Elkfork Partners LLC bought a new stake in shares of Humana during the first quarter valued at about $638,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

A number of equities research analysts recently weighed in on HUM shares. UBS AG restated a “neutral” rating and set a $250.00 price objective (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Cowen and Company reiterated a “buy” rating and issued a $230.00 price target on shares of Humana in a research report on Friday, July 14th. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a research report on Thursday, August 10th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $223.00 price target (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $244.35.

Humana Inc. (NYSE:HUM) traded down 0.33% during trading on Thursday, reaching $250.70. The company’s stock had a trading volume of 907,093 shares. The stock’s 50 day moving average is $248.81 and its 200-day moving average is $230.93. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $259.76. The firm has a market cap of $36.23 billion, a P/E ratio of 20.62 and a beta of 0.87.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period in the prior year, the company earned $2.30 earnings per share. On average, equities research analysts forecast that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Tuesday, August 29th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.64%. The ex-dividend date is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is 13.06%.

In other news, CEO Bruce D. Broussard sold 12,000 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the transaction, the chief executive officer now directly owns 80,086 shares of the company’s stock, valued at $20,172,061.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the completion of the transaction, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The disclosure for this sale can be found here. Over the last three months, insiders have sold 60,566 shares of company stock valued at $15,326,746. 0.80% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “South Dakota Investment Council Lowers Holdings in Humana Inc. (HUM)” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://ledgergazette.com/2017/09/14/humana-inc-hum-position-reduced-by-south-dakota-investment-council.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply